medRxivGenetic & Genomic MedicinePreprint
Leveraging Open-Source Large Language Models to Identify Undiagnosed Patients with Rare Genetic Aortopathies
Pankhuri SinghaliD, Zilinghan LiiD, Ze Xiao YangiD, Tarak NandiiD, Colleen Morse, Zachary Rodriguez, Alex Rodriguez, Volodymyr KindratenkoiD, Giorgio SirugoiD, Reed Edwin PyeritziD, Theodore G. DrivasiD, Ravi MadduriiD, Anurag VermaiD
Abstract
Rare genetic aortopathies are frequently undiagnosed due to phenotypic heterogeneity, and delayed diagnosis can lead to fatal cardiac outcomes. While genetic testing can enable early proactive interventions, it relies on primary care physicians to recognize a genetic basis for symptoms and then refer patients to clinical genetics. Broad-scale screening methods are needed to identify cases that do not fit an obvious diagnostic pattern. Clinical notes, rich in narrative details, may support the automated flagging of patients for genetic testing. Given the strength of Large Language Models (LLMs) in processing unstructured text, we developed an open-source LLM-enabled genetic testing recommendation pipeline, which leverages retrieval augmented generation (RAG) on curated genetic aortopathy-related corpora to utilize relevant clinical knowledge for identifying patients likely to benefit from genetic testing. The pipeline was validated using 22,510 patient progress notes from 500 individuals (250 cases, 250 controls) in the Penn Medicine BioBank, and successfully categorized 425 out of 499 patients, with one case requiring further clinician evaluation due to incomplete information. The pipeline achieved a patient-level recommendation accuracy of 0.834, precision of 0.835, sensitivity of 0.831, specificity of 0.836, F1-score of 0.833, and F3-score of 0.832. Our LLM-enabled workflow integrating RAG showed strong performance in recommending genetic testing for patients with rare genetic aortopathies. These findings illustrate the feasibility of using open-source LLMs to support identification of patients who may benefit from genetic testing based on free-text clinical notes, providing a potential decision-support tool to assist clinicians in earlier recognition of rare genetic disease risks.
- organism: human
- assay: electronic health records
- research focus: benchmarking
- approach: large language model
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Phenotypic signatures in clinical data enable systematic identification of patients for genetic testing
Theodore J. Morley, Lide Han, … Douglas M. Ruderfer·Nature MedicinePeer-reviewed·Jun 1, 2021
- Identifying barriers to genetic testing in subspecialty cardiac care
Sierra Pond, Genevie Echols, … Briana L. Sawyer·medRxiv·May 15, 2024
- DeepSeek as the paradigm shift in rare disease diagnosis-the power of a fully automated genetic variant classification system
Wei Ma, Grace Fong, … Brian Hon Yin Chung·medRxiv·Jun 3, 2025
- Systematic benchmarking demonstrates large language models have not reached the diagnostic accuracy of traditional rare-disease decision support tools
Justin Reese, Leonardo Chimirri, … Peter N. Robinson·European Journal of Human GeneticsPeer-reviewed·Feb 24, 2026
- Toward Precision Medicine in Aortopathies: Genetic Insights from a Brazilian Cohort Through Targeted Next-Generation Sequencing
Juliana R. Ferreira, Júlia Passarelli Pereira, … Glauber Monteiro Dias·medRxiv·Dec 22, 2023
- Early identification of rare disease using deep phenotyping of electronic health records
Tate Tunstall, Pauline C. Ng, … Matthew Rabinowitz·medRxiv·Sep 16, 2026